Cytokinetics Inc (NAS:CYTK)
$ 48.98 -10.25 (-17.31%) Market Cap: 5.14 Bil Enterprise Value: 6.35 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 43/100

Cytokinetics Inc Virtual Analyst & Investor Day Transcript

Jul 15, 2020 / 12:30PM GMT
Release Date Price: $28.96 (+3.87%)
Diane Weiser
Cytokinetics, Incorporated - SVP of Corporate Communications & IR

Good morning, and welcome to activate, inhibit, empower, changing the course of cardiovascular disease. I'm Diane Weiser, Senior Vice President of Corporate Communications and Investor Relations, and I want to thank you all for joining us this morning. We have an exciting agenda to go through with you today. We're going to be showing updates on our cardiovascular pipeline as well as strategies on building a commercial franchise. Before we get to the program, I do have some forward-looking statements, so bear with me.

Please note that portions of the following discussion, including our responses to questions, contain statements that relate to future events and performance rather than historical facts and constitute forward-looking statements. Our actual results might differ materially from those projected in these forward-looking statements. Additional information concerning factors that could cause our actual results to differ materially from those in these forward-looking statements is contained in our SEC

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot